| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 5.05e-08 | 15 | 51 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.13e-05 | 303 | 51 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 8.21e-05 | 562 | 51 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 1.91e-04 | 112 | 51 | 4 | GO:0090079 | |
| GeneOntologyMolecularFunction | mRNA binding | 3.47e-04 | 694 | 51 | 8 | GO:0003729 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.18e-03 | 20 | 51 | 2 | GO:0061665 | |
| GeneOntologyBiologicalProcess | female meiosis II | 4.95e-10 | 6 | 51 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 4.95e-10 | 6 | 51 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 4.95e-10 | 6 | 51 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 8.58e-09 | 29 | 51 | 5 | GO:0045948 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 1.07e-07 | 47 | 51 | 5 | GO:0001556 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | YTHDF1 SMG1 CASC3 TUT4 DAZ4 SF3A1 DAZ1 SCAF11 HNRNPUL1 DAZ3 DAZ2 KHDC4 CNOT3 | 2.41e-07 | 917 | 51 | 13 | GO:0016071 |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 2.92e-07 | 373 | 51 | 9 | GO:0006402 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 4.76e-07 | 26 | 51 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 8.43e-07 | 309 | 51 | 8 | GO:0061013 | |
| GeneOntologyBiologicalProcess | translational initiation | 8.71e-07 | 132 | 51 | 6 | GO:0006413 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 9.93e-07 | 31 | 51 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 9.96e-07 | 432 | 51 | 9 | GO:0006401 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.80e-06 | 464 | 51 | 9 | GO:0141188 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 2.06e-06 | 37 | 51 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 2.99e-06 | 91 | 51 | 5 | GO:0006446 | |
| GeneOntologyBiologicalProcess | oocyte development | 4.54e-06 | 99 | 51 | 5 | GO:0048599 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 4.58e-06 | 45 | 51 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 5.51e-06 | 103 | 51 | 5 | GO:0009994 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 7.21e-06 | 292 | 51 | 7 | GO:0043488 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 8.22e-06 | 52 | 51 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 1.02e-05 | 308 | 51 | 7 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.20e-05 | 443 | 51 | 8 | GO:1903311 | |
| GeneOntologyBiologicalProcess | female gamete generation | 1.79e-05 | 223 | 51 | 6 | GO:0007292 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 3.52e-05 | 151 | 51 | 5 | GO:0045727 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 3.54e-05 | 75 | 51 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 3.93e-05 | 77 | 51 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | oogenesis | 4.12e-05 | 156 | 51 | 5 | GO:0048477 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 4.60e-05 | 696 | 51 | 9 | GO:0034655 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 5.03e-05 | 82 | 51 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 6.34e-05 | 87 | 51 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 6.63e-05 | 88 | 51 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 1.13e-04 | 101 | 51 | 4 | GO:1902369 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.87e-04 | 115 | 51 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | YTHDF1 CASC3 TUT4 LATS1 SUPT5H DAZ4 DAZ1 DAZ3 DAZ2 CNOT3 TAB3 | 1.98e-04 | 1252 | 51 | 11 | GO:0009894 |
| GeneOntologyBiologicalProcess | regulation of translation | 2.02e-04 | 494 | 51 | 7 | GO:0006417 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 2.02e-04 | 845 | 51 | 9 | GO:0010564 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | ARID1B LATS1 DAZ4 BRD4 CDK19 PAXIP1 DACH1 DAZ1 DAZ3 DAZ2 ARID1A | 2.04e-04 | 1256 | 51 | 11 | GO:0051726 |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 2.07e-04 | 118 | 51 | 4 | GO:2000243 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 3.17e-04 | 132 | 51 | 4 | GO:0000956 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 3.23e-04 | 54 | 51 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 3.55e-04 | 136 | 51 | 4 | GO:0045445 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 4.41e-04 | 144 | 51 | 4 | GO:0045582 | |
| GeneOntologyBiologicalProcess | cell maturation | 5.06e-04 | 267 | 51 | 5 | GO:0048469 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 6.87e-04 | 162 | 51 | 4 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 8.60e-04 | 172 | 51 | 4 | GO:0051783 | |
| GeneOntologyBiologicalProcess | translation | 8.70e-04 | 824 | 51 | 8 | GO:0006412 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 9.48e-04 | 307 | 51 | 5 | GO:0090068 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.22e-03 | 189 | 51 | 4 | GO:0030216 | |
| GeneOntologyBiologicalProcess | keratinization | 1.30e-03 | 87 | 51 | 3 | GO:0031424 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 1.53e-03 | 92 | 51 | 3 | GO:0045661 | |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 1.58e-03 | 93 | 51 | 3 | GO:0034243 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 1.78e-03 | 354 | 51 | 5 | GO:0071695 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.87e-03 | 358 | 51 | 5 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.87e-03 | 358 | 51 | 5 | GO:0000377 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 1.88e-03 | 1153 | 51 | 9 | GO:0010608 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF462 BPTF NCOA6 EAF1 AKIRIN1 SUPT5H BRD4 PAXIP1 MAML1 ZMIZ1 | 1.88e-03 | 1390 | 51 | 10 | GO:0045944 |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 1.89e-03 | 99 | 51 | 3 | GO:0000245 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.96e-03 | 362 | 51 | 5 | GO:0000375 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 2.24e-03 | 105 | 51 | 3 | GO:0032784 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 2.33e-03 | 29 | 51 | 2 | GO:2000819 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 2.34e-03 | 226 | 51 | 4 | GO:0045580 | |
| GeneOntologyBiologicalProcess | cell cycle process | 2.45e-03 | 1441 | 51 | 10 | GO:0022402 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 2.52e-03 | 1446 | 51 | 10 | GO:0010628 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 2.54e-03 | 231 | 51 | 4 | GO:0006352 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 2.56e-03 | 385 | 51 | 5 | GO:0051251 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 2.58e-03 | 564 | 51 | 6 | GO:0051052 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CASC3 BPTF NCOA6 RANBP2 ARID1B EAF1 SUPT5H SF3A1 BRD4 CDK19 PAXIP1 ARID1A KHDC4 | 1.87e-05 | 1377 | 51 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 4.76e-05 | 269 | 51 | 6 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 6.81e-05 | 287 | 51 | 6 | GO:0035770 | |
| GeneOntologyCellularComponent | bBAF complex | 2.59e-04 | 10 | 51 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 3.46e-04 | 56 | 51 | 3 | GO:0008023 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 3.79e-04 | 12 | 51 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | npBAF complex | 5.21e-04 | 14 | 51 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 5.21e-04 | 14 | 51 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nuclear speck | 6.10e-04 | 431 | 51 | 6 | GO:0016607 | |
| GeneOntologyCellularComponent | cornified envelope | 6.40e-04 | 69 | 51 | 3 | GO:0001533 | |
| GeneOntologyCellularComponent | nBAF complex | 6.85e-04 | 16 | 51 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 8.71e-04 | 18 | 51 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.67e-03 | 96 | 51 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.43e-03 | 30 | 51 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | ATPase complex | 3.85e-03 | 129 | 51 | 3 | GO:1904949 | |
| GeneOntologyCellularComponent | ribosome | 4.06e-03 | 267 | 51 | 4 | GO:0005840 | |
| HumanPheno | Abnormal cerebral subcortex morphology | ZNF462 BPTF RANBP2 ARID1B ATN1 SACS HCN1 BRD4 PCLO CDK19 SEC31A ZMIZ1 ARID1A CNOT3 | 1.89e-06 | 1207 | 18 | 14 | HP:0010993 |
| HumanPheno | Abnormal cerebral white matter morphology | ZNF462 BPTF ARID1B ATN1 SACS HCN1 BRD4 PCLO CDK19 SEC31A ZMIZ1 ARID1A CNOT3 | 6.92e-06 | 1114 | 18 | 13 | HP:0002500 |
| HumanPheno | Abnormal corpus callosum morphology | ZNF462 ARID1B ATN1 SACS HCN1 BRD4 PCLO CDK19 SEC31A ZMIZ1 ARID1A CNOT3 | 8.75e-06 | 937 | 18 | 12 | HP:0001273 |
| HumanPheno | Y-linked inheritance | 2.93e-05 | 18 | 18 | 3 | HP:0001450 | |
| HumanPheno | Oligozoospermia | 4.40e-05 | 59 | 18 | 4 | HP:0000798 | |
| HumanPheno | Aplasia/Hypoplasia of the corpus callosum | 8.29e-05 | 772 | 18 | 10 | HP:0007370 | |
| HumanPheno | Cryptorchidism | 9.07e-05 | 780 | 18 | 10 | HP:0000028 | |
| HumanPheno | Hypoplasia of the corpus callosum | 1.06e-04 | 478 | 18 | 8 | HP:0002079 | |
| HumanPheno | Thin corpus callosum | 2.30e-04 | 868 | 18 | 10 | HP:0033725 | |
| HumanPheno | Abnormal male reproductive system physiology | ZNF462 ARID1B ATN1 SACS DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 3.10e-04 | 1314 | 18 | 12 | HP:0012874 |
| HumanPheno | Abnormality of the philtrum | 3.36e-04 | 726 | 18 | 9 | HP:0000288 | |
| HumanPheno | Abnormal male external genitalia morphology | ZNF462 ARID1B ATN1 SACS DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 3.48e-04 | 1329 | 18 | 12 | HP:0000032 |
| HumanPheno | Abnormal testis morphology | ZNF462 ARID1B ATN1 DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 4.05e-04 | 1129 | 18 | 11 | HP:0000035 |
| HumanPheno | Non-obstructive azoospermia | ZNF462 ARID1B ATN1 DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 4.15e-04 | 1132 | 18 | 11 | HP:0011961 |
| HumanPheno | Broad philtrum | 4.79e-04 | 45 | 18 | 3 | HP:0000289 | |
| HumanPheno | Abnormal external genitalia | ZNF462 ARID1B ATN1 SACS DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 4.80e-04 | 1372 | 18 | 12 | HP:0000811 |
| HumanPheno | Azoospermia | ZNF462 ARID1B ATN1 DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 5.08e-04 | 1157 | 18 | 11 | HP:0000027 |
| HumanPheno | Abnormal eyelid morphology | ZNF462 BPTF ARID1B ATN1 HCN1 BRD4 PCLO CDK19 SEC31A ZMIZ1 ARID1A CNOT3 | 6.23e-04 | 1408 | 18 | 12 | HP:0000492 |
| HumanPheno | Abnormal upper lip morphology | 6.44e-04 | 980 | 18 | 10 | HP:0000177 | |
| HumanPheno | Abnormality of upper lip vermillion | 6.49e-04 | 464 | 18 | 7 | HP:0011339 | |
| HumanPheno | Abnormal spermatogenesis | ZNF462 ARID1B ATN1 DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 6.58e-04 | 1190 | 18 | 11 | HP:0008669 |
| HumanPheno | Abnormality of the male genitalia | ZNF462 ARID1B ATN1 SACS DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 7.64e-04 | 1437 | 18 | 12 | HP:0010461 |
| HumanPheno | Hypoplastic fingernail | 7.77e-04 | 53 | 18 | 3 | HP:0001804 | |
| HumanPheno | Long eyelashes | 9.12e-04 | 129 | 18 | 4 | HP:0000527 | |
| HumanPheno | Abnormal male internal genitalia morphology | ZNF462 ARID1B ATN1 DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 9.79e-04 | 1243 | 18 | 11 | HP:0000022 |
| HumanPheno | Downslanted palpebral fissures | 9.85e-04 | 497 | 18 | 7 | HP:0000494 | |
| HumanPheno | Abnormal lip morphology | ZNF462 BPTF ARID1B ATN1 BRD4 PCLO CDK19 SEC31A ZMIZ1 ARID1A CNOT3 | 1.02e-03 | 1249 | 18 | 11 | HP:0000159 |
| HumanPheno | Hypoplastic fifth fingernail | 1.05e-03 | 14 | 18 | 2 | HP:0008398 | |
| HumanPheno | Abnormal internal genitalia | ZNF462 BPTF ARID1B ATN1 DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 1.15e-03 | 1498 | 18 | 12 | HP:0000812 |
| HumanPheno | Functional abnormality of male internal genitalia | ZNF462 ARID1B ATN1 DAZ4 BRD4 DAZ1 SEC31A ZMIZ1 DAZ3 DAZ2 ARID1A | 1.18e-03 | 1269 | 18 | 11 | HP:0000025 |
| HumanPheno | Autistic behavior | 1.21e-03 | 678 | 18 | 8 | HP:0000729 | |
| HumanPheno | Aggressive behavior | 1.23e-03 | 516 | 18 | 7 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 1.23e-03 | 516 | 18 | 7 | HP:0006919 | |
| MousePheno | absent ovarian follicles | 1.75e-05 | 51 | 43 | 4 | MP:0002777 | |
| MousePheno | embryonic lethality prior to tooth bud stage | SMG1 CASC3 BPTF RANBP2 EAF1 SF3A1 BRD4 YLPM1 PAXIP1 DHX33 SEC31A ARID1A RFX1 CNOT3 | 4.00e-05 | 1383 | 43 | 14 | MP:0013293 |
| MousePheno | embryonic lethality prior to organogenesis | SMG1 CASC3 BPTF RANBP2 SF3A1 BRD4 YLPM1 PAXIP1 DHX33 SEC31A ARID1A RFX1 CNOT3 | 4.23e-05 | 1204 | 43 | 13 | MP:0013292 |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | SMG1 CASC3 BPTF RANBP2 YLPM1 PAXIP1 SEC31A ARID1A RFX1 CNOT3 | 9.04e-05 | 772 | 43 | 10 | MP:0014259 |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | SMG1 CASC3 BPTF RANBP2 YLPM1 PAXIP1 SEC31A ARID1A RFX1 CNOT3 | 9.74e-05 | 779 | 43 | 10 | MP:0014257 |
| Domain | SPRR2 | 3.81e-07 | 6 | 51 | 3 | IPR029142 | |
| Domain | SPRR2 | 3.81e-07 | 6 | 51 | 3 | PF14820 | |
| Domain | BAF250_C | 7.31e-06 | 2 | 51 | 2 | IPR033388 | |
| Domain | BAF250_C | 7.31e-06 | 2 | 51 | 2 | PF12031 | |
| Domain | BAF250/Osa | 7.31e-06 | 2 | 51 | 2 | IPR021906 | |
| Domain | SPRR/LCE | 5.99e-05 | 28 | 51 | 3 | IPR026075 | |
| Domain | - | 7.50e-04 | 15 | 51 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 7.50e-04 | 15 | 51 | 2 | SM00501 | |
| Domain | ARID_dom | 7.50e-04 | 15 | 51 | 2 | IPR001606 | |
| Domain | ARID | 7.50e-04 | 15 | 51 | 2 | PS51011 | |
| Domain | ARID | 7.50e-04 | 15 | 51 | 2 | PF01388 | |
| Domain | zf-RanBP | 1.63e-03 | 22 | 51 | 2 | PF00641 | |
| Domain | ZnF_RBZ | 1.78e-03 | 23 | 51 | 2 | SM00547 | |
| Domain | ZF_RANBP2_2 | 1.78e-03 | 23 | 51 | 2 | PS50199 | |
| Domain | ZF_RANBP2_1 | 1.94e-03 | 24 | 51 | 2 | PS01358 | |
| Domain | Znf_RanBP2 | 2.11e-03 | 25 | 51 | 2 | IPR001876 | |
| Domain | Bromodomain_CS | 2.28e-03 | 26 | 51 | 2 | IPR018359 | |
| Domain | RRM_1 | 2.48e-03 | 208 | 51 | 4 | PF00076 | |
| Domain | RRM | 2.89e-03 | 217 | 51 | 4 | SM00360 | |
| Domain | RRM_dom | 3.40e-03 | 227 | 51 | 4 | IPR000504 | |
| Domain | RRM | 3.56e-03 | 230 | 51 | 4 | PS50102 | |
| Domain | - | 4.39e-03 | 244 | 51 | 4 | 3.30.70.330 | |
| Domain | BROMODOMAIN_1 | 4.58e-03 | 37 | 51 | 2 | PS00633 | |
| Domain | Bromodomain | 4.83e-03 | 38 | 51 | 2 | PF00439 | |
| Domain | Nucleotide-bd_a/b_plait | 5.34e-03 | 258 | 51 | 4 | IPR012677 | |
| Domain | BROMODOMAIN_2 | 5.60e-03 | 41 | 51 | 2 | PS50014 | |
| Domain | BROMO | 5.87e-03 | 42 | 51 | 2 | SM00297 | |
| Domain | Bromodomain | 5.87e-03 | 42 | 51 | 2 | IPR001487 | |
| Domain | - | 5.87e-03 | 42 | 51 | 2 | 1.20.920.10 | |
| Domain | ubiquitin | 7.31e-03 | 47 | 51 | 2 | PF00240 | |
| Domain | UBIQUITIN_2 | 9.56e-03 | 54 | 51 | 2 | PS50053 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.13e-06 | 29 | 39 | 4 | M48076 | |
| Pathway | WP_OVARIAN_INFERTILITY | 2.46e-06 | 35 | 39 | 4 | MM15948 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | CASC3 NCOA6 ARID1B TUT4 SPRR2A SPRR2B SPRR2D CDK19 PAXIP1 MAML1 ARID1A CNOT3 | 3.31e-04 | 1432 | 39 | 12 | M509 |
| Pubmed | YTHDF1 ZNF462 SMG1 BPTF NCOA6 ARID1B ATN1 YLPM1 PAXIP1 MAML1 DACH1 HELZ R3HDM2 SCAF11 ZMIZ1 HNRNPUL1 ARID1A RFX1 CNOT3 TAB3 | 5.92e-15 | 1429 | 52 | 20 | 35140242 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 4.44e-12 | 4 | 52 | 4 | 15066457 | |
| Pubmed | 4.44e-12 | 4 | 52 | 4 | 7670487 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 4.44e-12 | 4 | 52 | 4 | 26232607 | |
| Pubmed | 4.44e-12 | 4 | 52 | 4 | 11694340 | ||
| Pubmed | 4.44e-12 | 4 | 52 | 4 | 9321470 | ||
| Pubmed | 4.44e-12 | 4 | 52 | 4 | 19223287 | ||
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 4.44e-12 | 4 | 52 | 4 | 11095434 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 4.44e-12 | 4 | 52 | 4 | 11688365 | |
| Pubmed | 4.44e-12 | 4 | 52 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 4.44e-12 | 4 | 52 | 4 | 11883873 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 4.44e-12 | 4 | 52 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 4.44e-12 | 4 | 52 | 4 | 16963411 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 4.44e-12 | 4 | 52 | 4 | 12801575 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BPTF NCOA6 RANBP2 LATS1 ATN1 SF3A1 BRD4 YLPM1 AAK1 HELZ SCAF11 HNRNPUL1 RFX1 CNOT3 | 5.27e-12 | 774 | 52 | 14 | 15302935 |
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 23298641 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 23579190 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 2.22e-11 | 5 | 52 | 4 | 22223682 | |
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 2.22e-11 | 5 | 52 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 2.22e-11 | 5 | 52 | 4 | 9288969 | |
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 20008336 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 23456578 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 2.22e-11 | 5 | 52 | 4 | 8679003 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 2.22e-11 | 5 | 52 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 2.22e-11 | 5 | 52 | 4 | 8968756 | |
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 2.22e-11 | 5 | 52 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 2.22e-11 | 5 | 52 | 4 | 26411291 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 2.22e-11 | 5 | 52 | 4 | 10903443 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 2.22e-11 | 5 | 52 | 4 | 23223451 | |
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 34985827 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 11804965 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 9143498 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 2.22e-11 | 5 | 52 | 4 | 14648873 | |
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 2.22e-11 | 5 | 52 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 2.22e-11 | 5 | 52 | 4 | 8845845 | |
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 8896558 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 2.22e-11 | 5 | 52 | 4 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 2.22e-11 | 5 | 52 | 4 | 19783541 | |
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 22293198 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 17761180 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 19468308 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 9700189 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 2.22e-11 | 5 | 52 | 4 | 12200456 | |
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 11514340 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 21270429 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 11089564 | ||
| Pubmed | 2.22e-11 | 5 | 52 | 4 | 8661148 | ||
| Pubmed | 5.18e-11 | 18 | 52 | 5 | 22448252 | ||
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 32170089 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 6.65e-11 | 6 | 52 | 4 | 15066460 | |
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 16278232 | ||
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 20157580 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 6.65e-11 | 6 | 52 | 4 | 18452650 | |
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 17219433 | ||
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 6.65e-11 | 6 | 52 | 4 | 26077710 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 6.65e-11 | 6 | 52 | 4 | 16001084 | |
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 32962040 | ||
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 17526644 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 6.65e-11 | 6 | 52 | 4 | 1869307 | |
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 11390979 | ||
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 24086306 | ||
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 27632217 | ||
| Pubmed | 6.65e-11 | 6 | 52 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 6.65e-11 | 6 | 52 | 4 | 14611632 | |
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 6.65e-11 | 6 | 52 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 6.65e-11 | 6 | 52 | 4 | 31355046 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 6.65e-11 | 6 | 52 | 4 | 23417416 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF462 BPTF NCOA6 RANBP2 ARID1B ATN1 PAXIP1 MAML1 ZMIZ1 ARID1A | 1.05e-10 | 351 | 52 | 10 | 38297188 |
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 11410654 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 15081113 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 22699423 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 11604102 | ||
| Pubmed | 1.55e-10 | 7 | 52 | 4 | 10857750 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 1.55e-10 | 7 | 52 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 1.55e-10 | 7 | 52 | 4 | 26826184 | |
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 1.55e-10 | 7 | 52 | 4 | 16946704 | |
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 10951504 | ||
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 33749946 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 3.10e-10 | 8 | 52 | 4 | 23204224 | |
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 29883445 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 3.10e-10 | 8 | 52 | 4 | 32339196 | |
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 10823932 | ||
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 22621333 | ||
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 32686646 | ||
| Pubmed | 3.10e-10 | 8 | 52 | 4 | 11869379 | ||
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 5.57e-10 | 9 | 52 | 4 | 26378784 | |
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 5.57e-10 | 9 | 52 | 4 | 16310179 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 5.57e-10 | 9 | 52 | 4 | 19695304 | |
| Pubmed | 5.57e-10 | 9 | 52 | 4 | 28235998 | ||
| Pubmed | 5.57e-10 | 9 | 52 | 4 | 20159962 | ||
| Pubmed | 9.27e-10 | 10 | 52 | 4 | 10601091 | ||
| Pubmed | 9.27e-10 | 10 | 52 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 9.27e-10 | 10 | 52 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 9.27e-10 | 10 | 52 | 4 | 38433229 | |
| Pubmed | 9.27e-10 | 10 | 52 | 4 | 9922113 | ||
| Pubmed | 9.27e-10 | 10 | 52 | 4 | 23810942 | ||
| Pubmed | 9.27e-10 | 10 | 52 | 4 | 12837688 | ||
| Interaction | SMG7 interactions | YTHDF1 SMG1 NCOA6 ARID1B LATS1 YLPM1 PAXIP1 MAML1 DACH1 HELZ R3HDM2 HNRNPUL1 ARID1A CNOT3 | 4.80e-14 | 319 | 52 | 14 | int:SMG7 |
| Interaction | DAZL interactions | 3.32e-12 | 145 | 52 | 10 | int:DAZL | |
| Interaction | NUP35 interactions | YTHDF1 NCOA6 RANBP2 ARID1B ATN1 YLPM1 MAML1 HELZ ZMIZ1 ARID1A KHDC4 | 8.74e-09 | 424 | 52 | 11 | int:NUP35 |
| Interaction | EYA4 interactions | 1.09e-08 | 243 | 52 | 9 | int:EYA4 | |
| Interaction | TBR1 interactions | 1.57e-08 | 113 | 52 | 7 | int:TBR1 | |
| Interaction | FEV interactions | 4.75e-08 | 203 | 52 | 8 | int:FEV | |
| Interaction | SP7 interactions | 7.48e-08 | 304 | 52 | 9 | int:SP7 | |
| Interaction | RNF2 interactions | YTHDF1 NCOA6 RANBP2 SPRR2A SUPT5H SF3A1 BRD4 PCLO PAXIP1 HELZ DHX33 HNRNPUL1 RFX1 | 2.09e-07 | 866 | 52 | 13 | int:RNF2 |
| Interaction | EGR2 interactions | 2.72e-07 | 171 | 52 | 7 | int:EGR2 | |
| Interaction | TLX1 interactions | 3.18e-07 | 175 | 52 | 7 | int:TLX1 | |
| Interaction | ALG13 interactions | 4.30e-07 | 183 | 52 | 7 | int:ALG13 | |
| Interaction | YAP1 interactions | BPTF NCOA6 ARID1B LATS1 ATN1 SF3A1 BRD4 YLPM1 DACH1 PTPN21 HNRNPUL1 ARID1A RFX1 TAB3 | 4.57e-07 | 1095 | 52 | 14 | int:YAP1 |
| Interaction | TBXT interactions | 5.24e-07 | 116 | 52 | 6 | int:TBXT | |
| Interaction | FUBP3 interactions | 8.68e-07 | 297 | 52 | 8 | int:FUBP3 | |
| Interaction | ETV4 interactions | 9.31e-07 | 69 | 52 | 5 | int:ETV4 | |
| Interaction | RBMS1 interactions | 9.85e-07 | 207 | 52 | 7 | int:RBMS1 | |
| Interaction | PAX9 interactions | 1.02e-06 | 130 | 52 | 6 | int:PAX9 | |
| Interaction | SMC5 interactions | YTHDF1 BPTF NCOA6 RANBP2 ARID1B SF3A1 BRD4 YLPM1 DACH1 SCAF11 HNRNPUL1 ARID1A RFX1 | 1.07e-06 | 1000 | 52 | 13 | int:SMC5 |
| Interaction | NFIC interactions | 1.09e-06 | 210 | 52 | 7 | int:NFIC | |
| Interaction | TDRD3 interactions | 1.16e-06 | 212 | 52 | 7 | int:TDRD3 | |
| Interaction | YTHDF2 interactions | 1.26e-06 | 312 | 52 | 8 | int:YTHDF2 | |
| Interaction | FXR2 interactions | 1.38e-06 | 430 | 52 | 9 | int:FXR2 | |
| Interaction | MEX3B interactions | 1.57e-06 | 222 | 52 | 7 | int:MEX3B | |
| Interaction | ERG interactions | 1.62e-06 | 223 | 52 | 7 | int:ERG | |
| Interaction | NFIB interactions | 1.72e-06 | 142 | 52 | 6 | int:NFIB | |
| Interaction | SOX2 interactions | YTHDF1 ZNF462 BPTF NCOA6 RANBP2 ARID1B SUPT5H YLPM1 PAXIP1 MAML1 DACH1 HELZ ARID1A RFX1 CNOT3 | 1.85e-06 | 1422 | 52 | 15 | int:SOX2 |
| Interaction | PUM2 interactions | 1.86e-06 | 144 | 52 | 6 | int:PUM2 | |
| Interaction | NUP50 interactions | 2.44e-06 | 341 | 52 | 8 | int:NUP50 | |
| Interaction | YTHDF3 interactions | 3.11e-06 | 246 | 52 | 7 | int:YTHDF3 | |
| Interaction | CRX interactions | 3.84e-06 | 254 | 52 | 7 | int:CRX | |
| Interaction | PAX6 interactions | 4.11e-06 | 366 | 52 | 8 | int:PAX6 | |
| Interaction | SNRNP40 interactions | ZNF462 ARID1B ATN1 SUPT5H SF3A1 BRD4 SCAF11 HNRNPUL1 ARID1A KHDC4 | 4.43e-06 | 637 | 52 | 10 | int:SNRNP40 |
| Interaction | LSM14A interactions | 4.47e-06 | 260 | 52 | 7 | int:LSM14A | |
| Interaction | CEP85 interactions | 4.71e-06 | 169 | 52 | 6 | int:CEP85 | |
| Interaction | TLE3 interactions | 5.01e-06 | 376 | 52 | 8 | int:TLE3 | |
| Interaction | SOX9 interactions | 5.06e-06 | 97 | 52 | 5 | int:SOX9 | |
| Interaction | TEAD1 interactions | 5.94e-06 | 176 | 52 | 6 | int:TEAD1 | |
| Interaction | PRRC2A interactions | 6.42e-06 | 389 | 52 | 8 | int:PRRC2A | |
| Interaction | HNF4A interactions | 6.46e-06 | 275 | 52 | 7 | int:HNF4A | |
| Interaction | TNRC6A interactions | 7.27e-06 | 280 | 52 | 7 | int:TNRC6A | |
| Interaction | CELF1 interactions | 8.73e-06 | 288 | 52 | 7 | int:CELF1 | |
| Interaction | MEN1 interactions | YTHDF1 ZNF462 BPTF NCOA6 ARID1B ATN1 SF3A1 YLPM1 PAXIP1 SCAF11 ARID1A RFX1 | 9.13e-06 | 1029 | 52 | 12 | int:MEN1 |
| Interaction | HNF1B interactions | 9.21e-06 | 190 | 52 | 6 | int:HNF1B | |
| Interaction | FAM120C interactions | 9.49e-06 | 191 | 52 | 6 | int:FAM120C | |
| Interaction | PAX8 interactions | 9.79e-06 | 111 | 52 | 5 | int:PAX8 | |
| Interaction | KLF5 interactions | 1.07e-05 | 195 | 52 | 6 | int:KLF5 | |
| Interaction | CEBPA interactions | BPTF NCOA6 RANBP2 ARID1B SF3A1 BRD4 PAXIP1 MAML1 DACH1 HNRNPUL1 ARID1A RFX1 KHDC4 | 1.18e-05 | 1245 | 52 | 13 | int:CEBPA |
| Interaction | TPRX2 interactions | 1.31e-05 | 56 | 52 | 4 | int:TPRX2 | |
| Interaction | ETS1 interactions | 1.49e-05 | 121 | 52 | 5 | int:ETS1 | |
| Interaction | POU5F1 interactions | 1.64e-05 | 584 | 52 | 9 | int:POU5F1 | |
| Interaction | PAX7 interactions | 1.68e-05 | 124 | 52 | 5 | int:PAX7 | |
| Interaction | MECP2 interactions | ZNF462 BPTF RANBP2 ARID1B SACS SUPT5H SF3A1 BRD4 YLPM1 SEC31A HNRNPUL1 ARID1A RFX1 | 1.69e-05 | 1287 | 52 | 13 | int:MECP2 |
| Interaction | SIRT7 interactions | BPTF RANBP2 SUPT5H SF3A1 BRD4 YLPM1 HELZ SCAF11 HNRNPUL1 ARID1A | 1.72e-05 | 744 | 52 | 10 | int:SIRT7 |
| Interaction | SMAD3 interactions | 1.76e-05 | 447 | 52 | 8 | int:SMAD3 | |
| Interaction | CREBBP interactions | 2.00e-05 | 599 | 52 | 9 | int:CREBBP | |
| Interaction | R3HDM2 interactions | 2.03e-05 | 129 | 52 | 5 | int:R3HDM2 | |
| Interaction | NFIX interactions | 2.52e-05 | 227 | 52 | 6 | int:NFIX | |
| Interaction | BICRA interactions | 2.68e-05 | 67 | 52 | 4 | int:BICRA | |
| Interaction | NXF1 interactions | YTHDF1 CASC3 RANBP2 SUPT5H SF3A1 BRD4 YLPM1 DACH1 HELZ SEC31A HNRNPUL1 ARID1A KHDC4 | 2.69e-05 | 1345 | 52 | 13 | int:NXF1 |
| Interaction | BAG2 interactions | 2.70e-05 | 622 | 52 | 9 | int:BAG2 | |
| Interaction | GCM1 interactions | 2.84e-05 | 68 | 52 | 4 | int:GCM1 | |
| Interaction | NANOG interactions | 2.97e-05 | 481 | 52 | 8 | int:NANOG | |
| Interaction | OTUD4 interactions | 3.14e-05 | 236 | 52 | 6 | int:OTUD4 | |
| Interaction | RALY interactions | 3.42e-05 | 356 | 52 | 7 | int:RALY | |
| Interaction | AR interactions | ZNF462 NCOA6 ARID1B ATN1 BRD4 YLPM1 PAXIP1 MAML1 ZMIZ1 HNRNPUL1 ARID1A | 3.66e-05 | 992 | 52 | 11 | int:AR |
| Interaction | CPEB1 interactions | 3.68e-05 | 146 | 52 | 5 | int:CPEB1 | |
| Interaction | BMI1 interactions | 4.23e-05 | 659 | 52 | 9 | int:BMI1 | |
| Interaction | CPEB4 interactions | 5.05e-05 | 156 | 52 | 5 | int:CPEB4 | |
| Interaction | FXR1 interactions | 5.33e-05 | 679 | 52 | 9 | int:FXR1 | |
| Interaction | SOX7 interactions | 5.94e-05 | 82 | 52 | 4 | int:SOX7 | |
| Interaction | TP53BP1 interactions | 6.14e-05 | 533 | 52 | 8 | int:TP53BP1 | |
| Interaction | R3HDM1 interactions | 6.53e-05 | 84 | 52 | 4 | int:R3HDM1 | |
| Interaction | DCP1A interactions | 6.79e-05 | 166 | 52 | 5 | int:DCP1A | |
| Interaction | GSC interactions | 7.49e-05 | 87 | 52 | 4 | int:GSC | |
| Interaction | TERF2IP interactions | 7.84e-05 | 552 | 52 | 8 | int:TERF2IP | |
| Interaction | TAF15 interactions | 8.08e-05 | 408 | 52 | 7 | int:TAF15 | |
| Interaction | GATA4 interactions | 8.45e-05 | 411 | 52 | 7 | int:GATA4 | |
| Interaction | EWSR1 interactions | CASC3 NCOA6 ATN1 BRD4 PCLO MAML1 DACH1 HNRNPUL1 ARID1A KHDC4 | 9.09e-05 | 906 | 52 | 10 | int:EWSR1 |
| Interaction | PUM1 interactions | 9.30e-05 | 287 | 52 | 6 | int:PUM1 | |
| Interaction | HCFC2 interactions | 9.31e-05 | 92 | 52 | 4 | int:HCFC2 | |
| Interaction | WWTR1 interactions | 9.97e-05 | 422 | 52 | 7 | int:WWTR1 | |
| Interaction | TLX3 interactions | 1.00e-04 | 291 | 52 | 6 | int:TLX3 | |
| Interaction | ZFP36 interactions | 1.02e-04 | 181 | 52 | 5 | int:ZFP36 | |
| Interaction | SOX17 interactions | 1.05e-04 | 95 | 52 | 4 | int:SOX17 | |
| Interaction | FOXP3 interactions | 1.15e-04 | 432 | 52 | 7 | int:FOXP3 | |
| Interaction | TFCP2L1 interactions | 1.24e-04 | 99 | 52 | 4 | int:TFCP2L1 | |
| Interaction | SF1 interactions | 1.27e-04 | 304 | 52 | 6 | int:SF1 | |
| Interaction | SAP18 interactions | 1.30e-04 | 305 | 52 | 6 | int:SAP18 | |
| Interaction | TNIP2 interactions | YTHDF1 CASC3 RANBP2 ARID1B SUPT5H YLPM1 PAXIP1 DACH1 HELZ HNRNPUL1 | 1.37e-04 | 952 | 52 | 10 | int:TNIP2 |
| Interaction | RNF214 interactions | 1.50e-04 | 104 | 52 | 4 | int:RNF214 | |
| Interaction | TRIM33 interactions | 1.55e-04 | 453 | 52 | 7 | int:TRIM33 | |
| Interaction | TNFAIP8 interactions | 1.73e-04 | 42 | 52 | 3 | int:TNFAIP8 | |
| Interaction | SMARCA4 interactions | 1.74e-04 | 462 | 52 | 7 | int:SMARCA4 | |
| Interaction | PDCD6 interactions | 1.79e-04 | 204 | 52 | 5 | int:PDCD6 | |
| Interaction | RBM47 interactions | 1.79e-04 | 204 | 52 | 5 | int:RBM47 | |
| Interaction | DPY30 interactions | 1.79e-04 | 204 | 52 | 5 | int:DPY30 | |
| Interaction | EP300 interactions | CASC3 NCOA6 SUPT5H SF3A1 BRD4 YLPM1 PAXIP1 MAML1 SEC31A HNRNPUL1 ARID1A CNOT3 | 1.85e-04 | 1401 | 52 | 12 | int:EP300 |
| Interaction | SIRT6 interactions | 1.91e-04 | 628 | 52 | 8 | int:SIRT6 | |
| Interaction | CNOT3 interactions | 1.91e-04 | 207 | 52 | 5 | int:CNOT3 | |
| Interaction | PRMT5 interactions | 1.96e-04 | 471 | 52 | 7 | int:PRMT5 | |
| Cytoband | 1q21-q22 | 2.39e-06 | 23 | 52 | 3 | 1q21-q22 | |
| Cytoband | Yq11.223 | 3.96e-06 | 93 | 52 | 4 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 4.33e-04 | 311 | 52 | 4 | chrYq11 | |
| Cytoband | 6q25.1 | 8.62e-04 | 38 | 52 | 2 | 6q25.1 | |
| Cytoband | 19p13.1 | 1.37e-03 | 48 | 52 | 2 | 19p13.1 | |
| Cytoband | 1q22 | 1.93e-03 | 57 | 52 | 2 | 1q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q22 | 2.97e-03 | 71 | 52 | 2 | chr1q22 | |
| GeneFamily | Small proline rich proteins | 8.23e-07 | 11 | 32 | 3 | 1353 | |
| GeneFamily | AT-rich interaction domain containing | 3.14e-04 | 15 | 32 | 2 | 418 | |
| GeneFamily | RNA binding motif containing | 5.20e-04 | 213 | 32 | 4 | 725 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 6.24e-04 | 21 | 32 | 2 | 89 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 6.74e-09 | 12 | 52 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 6.74e-09 | 12 | 52 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 1.19e-07 | 23 | 52 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 4.16e-07 | 31 | 52 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 5.40e-07 | 33 | 52 | 4 | MM701 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.07e-06 | 300 | 52 | 7 | M8702 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 2.70e-06 | 199 | 52 | 6 | M7607 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 2.22e-05 | 432 | 52 | 7 | M41149 | |
| Coexpression | MADAN_DPPA4_TARGETS | 2.59e-05 | 86 | 52 | 4 | MM1312 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 BPTF RANBP2 TUT4 LATS1 AKIRIN1 SACS SF3A1 AAK1 HELZ SCAF11 ARID1A | 2.73e-05 | 1492 | 52 | 12 | M40023 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.89e-05 | 180 | 52 | 5 | M8239 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 3.53e-05 | 93 | 52 | 4 | MM1185 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_329_3P_GENES | 4.61e-05 | 35 | 52 | 3 | MM17501 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 4.67e-05 | 199 | 52 | 5 | M9255 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 4.78e-05 | 200 | 52 | 5 | M9317 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 2.38e-04 | 843 | 52 | 8 | M2356 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 2.64e-04 | 856 | 52 | 8 | M4500 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 2.90e-04 | 294 | 52 | 5 | M40873 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_155_3P_GENES | 2.97e-04 | 13 | 52 | 2 | MM17496 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.26e-05 | 595 | 52 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.97e-06 | 192 | 52 | 5 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.97e-06 | 192 | 52 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.04e-06 | 193 | 52 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.04e-06 | 193 | 52 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | moderate-Epithelial-Squamous|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.36e-06 | 197 | 52 | 5 | ab3c90a5b643b45d0b83939c6304b11f567c5d78 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.45e-06 | 198 | 52 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-06 | 199 | 52 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.62e-06 | 200 | 52 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.48e-05 | 158 | 52 | 4 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.73e-05 | 171 | 52 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 4.84e-05 | 172 | 52 | 4 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 174 | 52 | 4 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 176 | 52 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-05 | 178 | 52 | 4 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.90e-05 | 181 | 52 | 4 | 58651853f9c715075889856793df66ebe00c04f1 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.90e-05 | 181 | 52 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.90e-05 | 181 | 52 | 4 | faff2a34e391d053a17c926540e6cb46d94dd629 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.90e-05 | 181 | 52 | 4 | 5a9c332c0bf07cc20eaf8cf77b45e73668a6467d | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Basal/Club-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.90e-05 | 181 | 52 | 4 | 488a517f6e5543b648a2e72e0e04332fad776de6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-05 | 182 | 52 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PSB-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.16e-05 | 183 | 52 | 4 | 2cf798a2371c61322484ea16fdfae0acfa94f102 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 184 | 52 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 185 | 52 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.56e-05 | 186 | 52 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.56e-05 | 186 | 52 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 6.69e-05 | 187 | 52 | 4 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | BL-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.27e-05 | 191 | 52 | 4 | 3f9b8c4fb72ae6f3167b187e6715c4dcb3159f98 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.72e-05 | 194 | 52 | 4 | 53a34843d529ef395deb27086f71f7049a087bab | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.72e-05 | 194 | 52 | 4 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.87e-05 | 195 | 52 | 4 | 82d87fdb39ec15be9057e2d2ba5c1afb5f97aafe | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.87e-05 | 195 | 52 | 4 | dd8117dbd22892288f74a7314ab0b5080106936c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.03e-05 | 196 | 52 | 4 | 97e16d9833e4083d719ca7058d5fc9b11edb37e3 | |
| ToppCell | critical-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.19e-05 | 197 | 52 | 4 | cfbdaada7169afb68455724ae87032ff311b2d89 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.19e-05 | 197 | 52 | 4 | ac9c0c25cfeaabd53d332982c73fc6c47b0c6478 | |
| ToppCell | NS-control-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.19e-05 | 197 | 52 | 4 | ab965a0ba87efd3329d24a1ec123985f46fc17c0 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 8.19e-05 | 197 | 52 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | moderate-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.19e-05 | 197 | 52 | 4 | 2e13881f917d4f62a5b3e968e41c57e43300d988 | |
| ToppCell | critical-Epithelial-Squamous|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.19e-05 | 197 | 52 | 4 | eccc80d6ab79c46b10108de1cff3abeacfc105cd | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.19e-05 | 197 | 52 | 4 | b57d2e3413ef6dd1da56c45087926f2f3eab876c | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.35e-05 | 198 | 52 | 4 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.35e-05 | 198 | 52 | 4 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.35e-05 | 198 | 52 | 4 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.35e-05 | 198 | 52 | 4 | b7495369baba203490c067a58fc8456a778a12e4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.35e-05 | 198 | 52 | 4 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.51e-05 | 199 | 52 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 8.51e-05 | 199 | 52 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.68e-05 | 200 | 52 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.00e-04 | 123 | 52 | 3 | 51e49a64fbbf77e2ee21f45fd515d43282b11516 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.00e-04 | 123 | 52 | 3 | 11802979943a9205f10facda322fc220d4bf7133 | |
| Drug | boron trichloride | 3.34e-10 | 6 | 51 | 4 | CID000025135 | |
| Drug | desmethylazelastine | 3.98e-08 | 16 | 51 | 4 | CID000162558 | |
| Drug | dazmegrel | 8.44e-08 | 19 | 51 | 4 | CID000053555 | |
| Drug | YM 026 | 8.44e-08 | 19 | 51 | 4 | CID000004443 | |
| Drug | AZFd | 1.92e-07 | 23 | 51 | 4 | CID000196489 | |
| Drug | dansylaziridine | 1.92e-07 | 23 | 51 | 4 | CID000104008 | |
| Drug | kt S | 3.72e-07 | 66 | 51 | 5 | CID006399216 | |
| Drug | d-gluconhydroximo-1,5-lactam | 6.72e-07 | 31 | 51 | 4 | CID000003479 | |
| Drug | Vistar | 1.25e-06 | 36 | 51 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 1.25e-06 | 36 | 51 | 4 | CID000001649 | |
| Drug | molybdenum disulfide | 2.58e-06 | 43 | 51 | 4 | CID000014823 | |
| Drug | 2-chlorodideoxyadenosine | 2.58e-06 | 43 | 51 | 4 | CID000072194 | |
| Drug | propham | 2.84e-06 | 44 | 51 | 4 | CID000024685 | |
| Drug | ridogrel | 5.58e-06 | 52 | 51 | 4 | CID005362391 | |
| Drug | carbonyl sulfide | 6.13e-06 | 116 | 51 | 5 | CID000010039 | |
| Drug | azafagomine | 8.08e-06 | 57 | 51 | 4 | CID011957435 | |
| Drug | NSC56408 | 1.13e-05 | 62 | 51 | 4 | CID000005604 | |
| Drug | azelastine | 2.29e-05 | 74 | 51 | 4 | CID000002267 | |
| Drug | p11-13 | 2.41e-05 | 75 | 51 | 4 | CID000015759 | |
| Drug | 15 Z | 4.90e-05 | 5 | 51 | 2 | CID005322065 | |
| Drug | BW755C | 5.63e-05 | 93 | 51 | 4 | CID000047795 | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 6.61e-05 | 190 | 51 | 5 | 4340_DN | |
| Drug | bipy | 6.63e-05 | 97 | 51 | 4 | CID000001474 | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 4324_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 3923_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 4833_UP | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 1691_DN | |
| Drug | TXB2 (thromboxane B2 | 1.42e-04 | 118 | 51 | 4 | CID000005461 | |
| Disease | Male sterility due to Y-chromosome deletions | 5.51e-10 | 8 | 51 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 5.51e-10 | 8 | 51 | 4 | C1507149 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 2.68e-06 | 16 | 51 | 3 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 2.68e-06 | 16 | 51 | 3 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 2.68e-06 | 16 | 51 | 3 | cv:C1839071 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.92e-05 | 5 | 51 | 2 | C3281201 | |
| Disease | colon cancer (is_implicated_in) | 3.34e-05 | 36 | 51 | 3 | DOID:219 (is_implicated_in) | |
| Disease | Intellectual Disability | 1.18e-04 | 447 | 51 | 6 | C3714756 | |
| Disease | neuroblastoma (is_implicated_in) | 1.31e-04 | 10 | 51 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Coffin-Siris syndrome | 2.26e-04 | 13 | 51 | 2 | C0265338 | |
| Disease | testosterone measurement | 3.02e-04 | 1275 | 51 | 9 | EFO_0004908 | |
| Disease | Cardiovascular Abnormalities | 3.46e-04 | 16 | 51 | 2 | C0243050 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 3.92e-04 | 17 | 51 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 3.92e-04 | 17 | 51 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 3.92e-04 | 17 | 51 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 3.92e-04 | 17 | 51 | 2 | C0751780 | |
| Disease | May-White Syndrome | 3.92e-04 | 17 | 51 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 3.92e-04 | 17 | 51 | 2 | C0751781 | |
| Disease | Feeding difficulties | 4.40e-04 | 18 | 51 | 2 | C0232466 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 4.40e-04 | 18 | 51 | 2 | C0751779 | |
| Disease | free androgen index | 4.64e-04 | 374 | 51 | 5 | EFO_0007005 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.10e-03 | 117 | 51 | 3 | EFO_0004518, EFO_0005208 | |
| Disease | triglyceride measurement, response to selective serotonin reuptake inhibitor | 1.59e-03 | 34 | 51 | 2 | EFO_0004530, EFO_0005658 | |
| Disease | Global developmental delay | 1.59e-03 | 133 | 51 | 3 | C0557874 | |
| Disease | insomnia, total blood protein measurement | 2.16e-03 | 148 | 51 | 3 | EFO_0004536, EFO_0004698 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.30e-03 | 41 | 51 | 2 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.30e-03 | 41 | 51 | 2 | C0858252 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.90e-03 | 566 | 51 | 5 | EFO_0007660, EFO_0008354 | |
| Disease | Neuroblastoma | 3.01e-03 | 47 | 51 | 2 | C0027819 | |
| Disease | sitting height ratio | 3.54e-03 | 51 | 51 | 2 | EFO_0007118 | |
| Disease | interleukin 12 measurement | 3.81e-03 | 53 | 51 | 2 | EFO_0004753 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPPFQTQTPPQSLQQ | 46 | Q9H9L7 | |
| PPTTPQYSTQNLPSE | 16 | Q5W0A0 | |
| APPQAPPPQQNSTQT | 391 | Q9BWU1 | |
| PQAPPTPQQTPSTQA | 436 | Q2M2I8 | |
| QASTPPQTQTPQPNP | 201 | O60885 | |
| SNQPPKYTQPSLPSQ | 421 | P54259 | |
| PQPSYQTPPSLPNHI | 1606 | Q8NFD5 | |
| PSAQPQPQTQPQSPA | 2401 | Q12830 | |
| PNTETYLQPQITPNP | 146 | Q13117 | |
| PNTETYLQPQITPNP | 146 | Q9NR90 | |
| PVYSTPSPVENTPQN | 171 | Q9UI36 | |
| PPQPSHQQPYNSRPA | 221 | Q96JC9 | |
| NQHPQSPAVPPTYPS | 311 | O75175 | |
| QYQMPQSPSPCSPPQ | 676 | Q9Y2K5 | |
| QSPSPCSPPQMPQQY | 681 | Q9Y2K5 | |
| VQQTSTNPPLPEPGY | 966 | P49792 | |
| QQPPYSQQPPSQTPH | 481 | O14497 | |
| SQPPQLQSSQPPYSQ | 506 | O14497 | |
| LQSSQPPYSQQPSQP | 511 | O14497 | |
| PPYSQQPSQPPHQQS | 516 | O14497 | |
| SQQPYPQQPPHPFSQ | 436 | Q6ZW49 | |
| LTRPPPQYQDPTQGS | 666 | Q92585 | |
| QPPPPYPLTAANGQS | 371 | O95835 | |
| FTPQVQPTPTPQPSY | 3936 | Q9Y6V0 | |
| QPTPTPQPSYQLPSQ | 3941 | Q9Y6V0 | |
| QPFQLSTPQPLPHPY | 1036 | Q08174 | |
| QPQQPPPQLSPAYQA | 1411 | P42694 | |
| PQPYLQPSPMSSNPS | 406 | Q16825 | |
| YPQTPNNRPPSTEPS | 1221 | Q14686 | |
| TQPQQPSPQPQTPGS | 746 | O60741 | |
| PPPHLYPNTQAPSQV | 646 | O15234 | |
| PNTETYLQPQITPNP | 146 | Q9NQZ3 | |
| PNTETYLQPQITPNP | 311 | Q9NQZ3 | |
| PNTETYLQPQITPNP | 476 | Q9NQZ3 | |
| QQPPLAQPSASPYPE | 51 | Q9H6R0 | |
| PTQYPITQVQPPAST | 406 | Q7Z7F0 | |
| PNTETYLQPQITPNP | 146 | Q86SG3 | |
| PNTETYLQPQITPNP | 311 | Q86SG3 | |
| PPPPPSQQVNYIASQ | 1281 | Q99590 | |
| TPQNPPNPPSQQSTL | 2136 | Q58EX2 | |
| PNPPSQQSTLYRPPS | 2141 | Q58EX2 | |
| LYSNQIPASPNTPVP | 1366 | Q9NZJ4 | |
| PPPTAQTYPQPSYNQ | 801 | Q9BUJ2 | |
| NRSAATPPSQPPQQP | 146 | Q8N5C8 | |
| YTELQAAPPPSQPPQ | 6 | P22670 | |
| PQPPTAAATPQPQYV | 41 | P22670 | |
| QPTGAPTPSPAPQQY | 86 | P22670 | |
| SYQTPQNPGIVPRPS | 2236 | Q96Q15 | |
| STSQALYPGPNQPPI | 346 | O94933 | |
| NPQTPGYPDPSSPQV | 856 | O00267 | |
| SSPQVNPQYNPQTPG | 866 | O00267 | |
| PSPQGSYQPSPSPQS | 896 | O00267 | |
| PQSGPALQPTPYSQR | 36 | Q66K80 | |
| NEIPQQPPPPSSATN | 551 | Q15459 | |
| QPENPYPAQPTVVPT | 21 | O15393 | |
| PPQQCQQKYPPVTPS | 46 | P35326 | |
| QQKYPPVTPSPPCQS | 51 | P35326 | |
| PPQQCQQKYPPVTPS | 46 | P35325 | |
| PPQQCQQKYPPVTPS | 46 | P22532 | |
| PAQPSPSQSPPSQSY | 186 | P49750 | |
| QQPQPPTQAAPLHPY | 586 | Q96JM2 | |
| QQPVAPPTSNAYPNT | 896 | O94979 | |
| SESPSYSPQPQPFPQ | 1421 | Q5TAX3 | |
| PTPPPPYSAFQLQQQ | 116 | Q9NX94 | |
| PSQPSSGQYPPPTVN | 451 | Q9ULJ6 | |
| PAQPPALAQPQYQSP | 306 | Q9BYJ9 |